Medtronic Plc

NYSE:MDT  
80.62
+1.44 (+1.82%)
7:57:39 PM EDT: $80.62 0.00 (0.00%)
Products

FDA Says Medtronic Recalls Mahurkar Acute Dual Lumen High Flow Hemodialysis Catheters For Potential Catheter Hub Defect

Published: 01/30/2023 17:15 GMT
Medtronic Plc (MDT) - :fda - Medtronic Recalls Mahurkar Acute Dual Lumen High Flow Hemodialysis Catheters for Potential Catheter Hub Defect.
FDA - Identified Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters Recall As a Class I Recall.
FDA - There Have Been Two Injuries Reported Related to Use of Medtronic's Defective Catheter and No Reports of Death.